ATE107853T1 - Orales, melatonin enthaltendes arzneimittel. - Google Patents

Orales, melatonin enthaltendes arzneimittel.

Info

Publication number
ATE107853T1
ATE107853T1 AT92903762T AT92903762T ATE107853T1 AT E107853 T1 ATE107853 T1 AT E107853T1 AT 92903762 T AT92903762 T AT 92903762T AT 92903762 T AT92903762 T AT 92903762T AT E107853 T1 ATE107853 T1 AT E107853T1
Authority
AT
Austria
Prior art keywords
pct
oral medication
containing melatonin
medication containing
date feb
Prior art date
Application number
AT92903762T
Other languages
English (en)
Inventor
Graziella Bruno
Original Assignee
Medea Res Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medea Res Srl filed Critical Medea Res Srl
Application granted granted Critical
Publication of ATE107853T1 publication Critical patent/ATE107853T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
AT92903762T 1990-08-10 1991-08-07 Orales, melatonin enthaltendes arzneimittel. ATE107853T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02126390A IT1243193B (it) 1990-08-10 1990-08-10 Composizioni farmaceutiche orali a base di melatonina

Publications (1)

Publication Number Publication Date
ATE107853T1 true ATE107853T1 (de) 1994-07-15

Family

ID=11179218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903762T ATE107853T1 (de) 1990-08-10 1991-08-07 Orales, melatonin enthaltendes arzneimittel.

Country Status (7)

Country Link
US (1) US5362745A (de)
EP (1) EP0542930B1 (de)
AT (1) ATE107853T1 (de)
AU (1) AU8332791A (de)
DE (1) DE69102704T2 (de)
IT (1) IT1243193B (de)
WO (1) WO1992002207A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
DE19641672A1 (de) * 1996-10-10 1998-04-16 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen
ES2209649B1 (es) * 2002-12-09 2005-03-16 Carlos Arana Molina (Titular Al 25%) Utilizacion de la melatonina para la higiene bucodental para uso humano y veterinario como producto activo.
DE10340741A1 (de) * 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Formulierung auf Phospholipidbasis
JP5600058B2 (ja) 2007-04-11 2014-10-01 ファーマシューティカル プロダクションズ, インコーポレイテッド メラトニンタブレットならびに調剤及び使用方法
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
RU2590979C2 (ru) 2011-02-11 2016-07-10 ЗедЭкс ФАРМА, ЭлЭлСи Составы l-ментола, состоящие из множества частиц, и связанные с ними способы
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
RS58325B1 (sr) 2013-04-23 2019-03-29 Zx Pharma Llc Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
NL2015272B1 (en) 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
US10806789B2 (en) * 2017-05-12 2020-10-20 The LIV Group Inc. Composition for enhanced absorption of supplements
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
BR102018003456A2 (pt) * 2018-02-22 2019-09-10 Cosmed Ind De Cosmeticos E Medicamentos S A composição farmacêutica na forma de suspensão aquosa e uso de uma composição farmacêutica na forma de suspensão aquosa

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2435365A1 (de) * 1973-12-31 1976-01-29 Luigi Di Bella Pharmazeutisches mittel fuer die behandlung von allen leukaemieformen und neurotischen syndromen
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
FR2618351B1 (fr) * 1987-07-20 1991-01-11 Mero Rousselot Satia Emulsions gelifiees transparentes et leur procede d'obtention

Also Published As

Publication number Publication date
IT9021263A1 (it) 1992-02-10
IT1243193B (it) 1994-05-24
IT9021263A0 (it) 1990-08-10
DE69102704D1 (de) 1994-08-04
AU8332791A (en) 1992-03-02
DE69102704T2 (de) 1995-02-23
US5362745A (en) 1994-11-08
EP0542930B1 (de) 1994-06-29
WO1992002207A1 (en) 1992-02-20
EP0542930A1 (de) 1993-05-26

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
DE69620877D1 (de) Arzneimittelformulierungen für il-12
NO954320L (no) Lyosfærer omfattende gonadotropin
SE9504661D0 (sv) New compounds
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
DK0706378T3 (da) Ny farmaceutisk formulering.
PT83873A (de) Arzneimittel mit antitumorwirkung
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
DE59508891D1 (de) Hautpflegemittel
DK0758248T3 (da) Formuleringer til faktor IX
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
HRP20000781B1 (hr) Šumeći pripravci
SE9504662D0 (sv) New compounds
DE69007956D1 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
IT9048066A0 (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono.
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
KR970702880A (ko) 신규한 펩티드 활성 물질 및 그의 제조 방법(New Peptide Active Substance And Production Thereof)
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
SE8704049D0 (sv) Novel pharmacological compounds
MX9203372A (es) Composiciones farmaceuticas de buspirona y sales de la misma, de aplicacion oral.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties